VERADERMICS (MANE) Stock Price, News & Analysis
Company Description
VERADERMICS (NYSE: MANE) is classified in the biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $4.6B, ranking #1,606 among all listed U.S. companies by market cap.
For FY2025, VERADERMICS reported net income of -$70.0M and diluted earnings per share of -$111.91.
This page collects what Stock Titan holds for MANE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VERADERMICS (MANE) stock last closed at $112.71. At a market capitalization of $4.6B, MANE is classified as a mid-cap stock with approximately 41.8M shares outstanding.
MANE Rankings
Latest News
VERADERMICS has 10 recent news articles, with the latest published 6 days ago. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, clinical trial, conferences, private placement, offering. View all MANE news →
SEC Filings
VERADERMICS has filed 5 recent SEC filings, including 1 Form 4, 1 Form EFFECT, 1 Form SCHEDULE 13D/A, 1 Form 144/A. The most recent filing was submitted on August 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MANE SEC filings →
Insider Radar
Insider selling at VERADERMICS over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
operating income reached -$72.3M, and net income was -$70.0M. Diluted earnings per share stood at -$111.91. The company generated -$71.6M in operating cash flow. With a current ratio of 16.66, the balance sheet reflects a strong liquidity position.
Upcoming Events
Study 306 Topline Data
Female trials topline data
Study 306 topline data
VERADERMICS has 3 upcoming scheduled events. The next event, "Study 306 Topline Data", is scheduled for January 1, 2027 (in 136 days). Investors can track these dates to stay informed about potential catalysts that may affect the MANE stock price.
Short Interest History
Short interest in VERADERMICS (MANE) currently stands at 3.9 million shares, up 3.3% from the previous reporting period, representing 10.2% of the float. Since February 2026, short interest has increased by 280.7%. This moderate level of short interest indicates notable bearish positioning. The 7.0 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for VERADERMICS (MANE) currently stands at 7.0 days, up 97.7% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 310.5% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.7 to 7.0 days.
MANE Company Profile & Sector Positioning
VERADERMICS (MANE) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NYSE.